摘要
目的:获得低毒性但仍保留其免疫活性、高纯度的重组D227A突变型金葡菌肠毒素A蛋白(rSEA_(D227A))。方法:利用PCR技术克隆含D227A突变的SEA基因并原核表达,用盐酸胍溶解包涵体并进行梯度透析复性;使用StrepⅡ亲和层析来纯化蛋白;免疫印迹和LC-MS/MS进行鉴定。结果:成功克隆SEA的D227A突变体,获得了高纯度的rSEA_(D227A)蛋白。LCMS/MS分析证实,胰酶消化后的rSEA_(D227A)肽段序列与数据库中SEA的序列匹配。结论:获得了高纯度rSEA_(D227A)蛋白,为SEA的进一步基础研究和临床应用提供了实验基础。
Objective:To obtain recombinant D227 A mutation Staphylococcal enterotoxin A protein(rSEA_(D227A)) with low toxicity but still retain its immunological activity and high purity.Methods:The SEA gene containing D227 A mutation was cloned by PCR.By constructing p ET44 a-SEAD227 Avector and transfecting the expression strain Rosetta,inclusion bodies were solubilized with guanidium hydrochloride and refolded by gradient dialysis;proteins were purified using StrepⅡ affinity chromatography,and identified by Western blot and high performance liquid chromatography-mass spectrometry(LC-MS/MS).Results:The D227 A mutation of SEA was cloned and the expression system of Rosetta-rSEA_(D227A) was constructed.The purified rSEA_(D227A) protein was obtained by refolding with gradient dialysis and affinity purification.LC-MS/MS analysis confirmed that the tryptic digested rSEA_(D227A) peptide sequences matched the sequences of SEA in the database.Conclusion:The rSEA_(D227A) protein in high purity was obtained,which provided the experimental basis for further basic research and clinical application of SEA.
作者
刘雪婷
曾丽萍
谢洋
张建国
邹泽红
陶爱林
LIU Xue-Ting;ZENG Li-Ping;XIE Yang;ZHANG Jian-Guo;ZOU Ze-Hong;TAO Ai-Lin(The Second Affiliated Hospital of Guangzhou Medical University, Guangdong Province Key Laboratory of Allergy & Clinical Immunology, Allergy Research Branch of the State Key Laboratory of Respiratory Disease, Guangzhou 510260, China)
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2018年第6期882-886,891,共6页
Chinese Journal of Immunology
基金
国家自然科学基金(81301948
30640033)
广州市过敏反应临床医学研究与转化中心建设项目(穗科创字[2016]171号)的资助